WPRIM Management System> DCMS> Chinese Journal of Laboratory Medicine> 2012> > 11

Volume: Issue: 11

1. Adapting the demands of tumor individualized therapy and promoting the development of molecular diagnostic career in China Page:961—962
2. The importance of quality assurance in laboratory test for personalized medicine Page:963—966
3. Pharmacogenomics and individual therapy of immunosuppressive drugs in transplant recipients Page:967—970
4. Progress in the detection of Kras, EGFR, BRAF mutations and its clinical application Page:971—977
5. Advancement on the pharmacogenomics of immunosuppressant Page:978—985
6. Establishment of a novel mutant-enriched liquid chip technology for detecting EGFR mutations in plasma of patients with non-small cell lung cancer Page:986—992
7. The detection of BRAF mutations and its clinical significance in colorectal cancer patients Page:993—999
8. Establishment of a novel ring primer real-time PCR for quantification of the mRNA expression levels of HER2 gene Page:1000—1005
9. Application of gene sequencing in detection of BRCA1/2 gene mutations in breast cancer patients and risk assessment Page:1006—1009
10. To establish a method for detecting genetic polymorphism of CYP2C9 1075A ＞ C and VKORC1-1639 G ＞ A and evaluate the correlation of SNP with Warfarin dose Page:1010—1015
11. Clinical application of detection of Warfarin-related gene polymorphisms by DNA sequencing Page:1016—1020
12. The signification and method of HBeAg gray zone setting and its cut-off verification in chemiluminescent assay Page:1045—1047
13. Antimicrobial resistance surveillance of gram-positive cocci isolated from 14 hospitals in China in 2011 Page:1021—1028
14. Value of serum IgG4 in diagnosis of IgG4-related disease and in differentiation from rheumatic diseases Page:1029—1033
15. Diagnostic value of Golgi-73 and AFP alone or combination in primary hepatocelluar carcinoma Page:1034—1037
16. Performance evaluation of nine commonly used urine albumin assay systems Page:1038—1044
17. Nucleic acid testing for point-of-care using：advances in technologies and future perspectives Page:824—827
18. C-reactive protein and autoimmune diseases Page:876—878
19. Quality control in maternal serum prenatal screening in the second trimester Page:870—875
20. Applications of two analytical specifications in the external quality assessment schemes and the external comparision of internal quality control Page:866—869
21. The feasibility study of Ion Proton semiconductor sequencing platform in the non-invasive prenatal genetic diagnosis Page:861—865
22. The etiology, molecular epidemiology and clinical characteristics of Clostridium difficile infections in Xiangya Hospital Page:855—860
23. The evaluation of clinical value of antiphospholipid syndrome related autoantibodies Page:851—854
24. Clinical significance of screening autoantibodies in individuals of physical examination Page:847—850
25. Development and performance evaluation of a novel quantitative fluorescence immunochromatography for NT-proBNP Page:842—846
26. The evaluation of dot immunogold filtration method in detection of serum SAA and its clinical value of diagnosing the infectious diseases of children Page:836—841
27. Preparation of the mixed serum calibrators for C-reactive protein Page:832—835
28. The research advance of the relationship between vitamin D binding protein and cancer Page:828—831
29. Technical requirements for point-of-care testing in vitro diagnostic reagents registration Page:812—816
30. A novel molecular point-of-care testing detection technology for infectious pathogens：GeneXpert Page:820—823
31. Application and development of point-of-care testing in domain of tumor markers Page:808—811
32. Analysis of application and management status of point-of-care testing in China and America Page:804—807
33. Promotion from qualitative to quantitative test is one of challenges of point-of-care testing development Page:801—803

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.